Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2

N Engl J Med. 2021 Jun 24;384(25):2453-2454. doi: 10.1056/NEJMc2104036. Epub 2021 Apr 7.

Authors

Yaniv Lustig¹, Ital Nemet¹, Limor Kliker¹, Neta Zuckerman¹, Ruti Yishai², Sharon Alroy-Preis², Ella Mendelson³, Michal Mandelboim³

Affiliations

¹ Ministry of Health, Tel Hashomer, Israel.
² Ministry of Health, Jerusalem, Israel.
³ Ministry of Health, Tel Hashomer, Israel [email protected].

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Neutralizing / blood*
Antibodies, Viral / blood*
BNT162 Vaccine
COVID-19 / immunology
COVID-19 / prevention & control*
COVID-19 Vaccines / immunology*
Humans
Neutralization Tests
SARS-CoV-2 / immunology*

Substances

Antibodies, Neutralizing
Antibodies, Viral
COVID-19 Vaccines
BNT162 Vaccine